{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:19:59Z","timestamp":1787933999237,"version":"build-2784847793"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T00:00:00Z","timestamp":1795046400000},"content-version":"am","delay-in-days":291,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1K08CA293255-0"],"award-info":[{"award-number":["1K08CA293255-0"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.otc.2025.09.001","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:26:59Z","timestamp":1760138819000},"page":"93-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Surgically Based Deintensification for Oropharyngeal Cancer"],"prefix":"10.1016","volume":"59","author":[{"given":"Michael C.","family":"Topf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kjaergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine Po","family":"Ling Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Christopher","family":"Holsinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.otc.2025.09.001_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","article-title":"Evidence for a causal association between human papillomavirus and a subset of head and neck cancers","volume":"92","author":"Gillison","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"10.1016\/j.otc.2025.09.001_bib2","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1056\/NEJMoa065497","article-title":"Case-control study of human papillomavirus and oropharyngeal cancer","volume":"356","author":"D\u2019Souza","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.otc.2025.09.001_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.otc.2025.09.001_bib4","first-page":"118","article-title":"Cancers with increasing incidence trends in the United States: 1999 through 2008","volume":"62","author":"Simard","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.otc.2025.09.001_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.6004\/jnccn.2011.0055","article-title":"The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms?","volume":"9","author":"Sturgis","year":"2011","journal-title":"J Natl Compr Cancer Netw"},{"issue":"32","key":"10.1016\/j.otc.2025.09.001_bib6","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.otc.2025.09.001_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.oraloncology.2017.09.015","article-title":"40-year incidence trends for oropharyngeal squamous cell carcinoma in the United States","volume":"74","author":"Osazuwa-Peters","year":"2017","journal-title":"Oral Oncol"},{"issue":"5","key":"10.1016\/j.otc.2025.09.001_bib8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.oraloncology.2013.12.019","article-title":"Epidemiology of HPV-associated oropharyngeal cancer","volume":"50","author":"Pytynia","year":"2014","journal-title":"Oral Oncol"},{"issue":"23","key":"10.1016\/j.otc.2025.09.001_bib9","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1002\/cncr.27631","article-title":"Late dysphagia after radiotherapy-based treatment of head and neck cancer","volume":"118","author":"Hutcheson","year":"2012","journal-title":"Cancer"},{"issue":"21","key":"10.1016\/j.otc.2025.09.001_bib10","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1200\/JCO.2007.14.8841","article-title":"Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis","volume":"26","author":"Machtay","year":"2008","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.otc.2025.09.001_bib11","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/archotol.133.12.1220","article-title":"Transoral robotic surgery: radical tonsillectomy","volume":"133","author":"Weinstein","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"8","key":"10.1016\/j.otc.2025.09.001_bib12","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/01.mlg.0000227184.90514.1a","article-title":"Transoral robotic surgery (TORS) for base of tongue neoplasms","volume":"116","author":"O'Malley","year":"2006","journal-title":"Laryngoscope"},{"issue":"6","key":"10.1016\/j.otc.2025.09.001_bib13","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1212\/01.WNL.0000164714.90354.7D","article-title":"Robot-assisted pharyngeal and laryngeal microsurgery: results of robotic cadaver dissections","volume":"115","author":"Hockstein","year":"2005","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.otc.2025.09.001_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hed.21500","article-title":"Transoral robotic surgery and human papilloma virus status: oncologic results","volume":"33","author":"Cohen","year":"2011","journal-title":"Head Neck"},{"issue":"8","key":"10.1016\/j.otc.2025.09.001_bib15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.oraloncology.2014.04.005","article-title":"Oncologic, functional and surgical outcomes of primary Transoral Robotic Surgery for early squamous cell cancer of the oropharynx: a systematic review","volume":"50","author":"Kelly","year":"2014","journal-title":"Oral Oncol"},{"issue":"12","key":"10.1016\/j.otc.2025.09.001_bib16","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/jamaoto.2015.1508","article-title":"Oncologic outcomes after transoral robotic surgery: a multi-institutional study","volume":"141","author":"de Almeida","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"11","key":"10.1016\/j.otc.2025.09.001_bib17","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/hed.25382","article-title":"Decreased gastrostomy tube incidence and weight loss after transoral robotic surgery for low- to intermediate-risk oropharyngeal squamous cell carcinoma","volume":"40","author":"Heah","year":"2018","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.otc.2025.09.001_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00405-014-2985-7","article-title":"Functional outcomes after TORS for oropharyngeal cancer: a systematic review","volume":"272","author":"Hutcheson","year":"2015","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.otc.2025.09.001_bib19","unstructured":"NCCN Clinical Practicve Guidelines in Oncology (NCCN Guidelines) for Head and Neck Cancers V.4.2024. National Comprehensive Cancer Network, Inc. 2024. All rights reserved. [Accessed June 14, 2025]."},{"issue":"Issue 2","key":"10.1016\/j.otc.2025.09.001_bib20","first-page":"S2","article-title":"Interim futility results of NRG-HN005, A randomized, phase II\/III non-inferiority trial for non-smoking p16+ oropharyngeal cancer patients","volume":"120","author":"SSea","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10166","key":"10.1016\/j.otc.2025.09.001_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"issue":"10166","key":"10.1016\/j.otc.2025.09.001_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.otc.2025.09.001_bib23","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1245\/s10434-013-3054-y","article-title":"Clinical research in surgical oncology: an analysis of ClinicalTrials.gov","volume":"20","author":"Menezes","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.otc.2025.09.001_bib24","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.45511","article-title":"Analysis of registered clinical trials in surgical oncology, 2008-2020","volume":"5","author":"Wong","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.otc.2025.09.001_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104797","article-title":"A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311","volume":"110","author":"Ferris","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.otc.2025.09.001_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1471-2407-13-133","article-title":"Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial","volume":"13","author":"Nichols","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.otc.2025.09.001_bib27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1186\/s12885-015-1598-x","article-title":"PATHOS: a phase II\/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer","volume":"15","author":"Owadally","year":"2015","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.otc.2025.09.001_bib28","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/jamaoncol.2022.0615","article-title":"Assessment of toxic effects and survival in treatment deescalation with radiotherapy vs transoral surgery for HPV-associated oropharyngeal squamous cell carcinoma: the ORATOR2 phase 2 randomized clinical trial","volume":"8","author":"Palma","year":"2022","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.otc.2025.09.001_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0360-3016(91)90133-O","article-title":"Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03","volume":"20","author":"Tupchong","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.otc.2025.09.001_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0360-3016(93)90167-T","article-title":"Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial","volume":"26","author":"Peters","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.otc.2025.09.001_bib31","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ijrobp.2017.02.218","article-title":"Final report of a prospective randomized trial to evaluate the dose-response relationship for postoperative radiation therapy and pathologic risk groups in patients with head and neck cancer","volume":"98","author":"Rosenthal","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.otc.2025.09.001_bib32","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.prro.2024.05.007","article-title":"Radiation therapy for HPV-positive oropharyngeal squamous cell carcinoma: an ASTRO clinical practice guideline","volume":"14","author":"Margalit","year":"2024","journal-title":"Pract Radiat Oncol"},{"issue":"2","key":"10.1016\/j.otc.2025.09.001_bib33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1200\/JCO.21.01752","article-title":"Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN cancer research group trial (E3311)","volume":"40","author":"Ferris","year":"2022","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.otc.2025.09.001_bib34","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1200\/JOP.2012.000818","article-title":"Closing the quality loop: facilitating improvement in oncology practice through timely access to clinical performance indicators","volume":"9","author":"Srigley","year":"2013","journal-title":"J Oncol Pract"},{"issue":"22","key":"10.1016\/j.otc.2025.09.001_bib35","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.19.00463","article-title":"Phase II evaluation of aggressive dose de-escalation for adjuvant chemoradiotherapy in human papillomavirus-associated oropharynx squamous cell carcinoma","volume":"37","author":"Ma","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.otc.2025.09.001_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/hed.26477","article-title":"Human papillomavirus oropharynx carcinoma: aggressive de-escalation of adjuvant therapy","volume":"43","author":"Moore","year":"2021","journal-title":"Head Neck"},{"issue":"12","key":"10.1016\/j.otc.2025.09.001_bib37","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/BF02553933","article-title":"An evaluation of combined therapy for squamous cell cancer of the anal canal","volume":"27","author":"Nigro","year":"1984","journal-title":"Dis Colon Rectum"},{"issue":"23","key":"10.1016\/j.otc.2025.09.001_bib38","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1200\/JCO.2013.53.9163","article-title":"Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: radiation Therapy Oncology Group RTOG-0234","volume":"32","author":"Harari","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.otc.2025.09.001_bib39","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hed.25055","article-title":"Transoral robotic surgery for oropharyngeal carcinoma: surgical margins and oncologic outcomes","volume":"40","author":"Moore","year":"2018","journal-title":"Head Neck"},{"issue":"6","key":"10.1016\/j.otc.2025.09.001_bib40","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/onco.13742","article-title":"De-escalated adjuvant therapy after transoral robotic surgery for human papillomavirus-related oropharyngeal carcinoma: the Sinai robotic surgery (SIRS) trial","volume":"26","author":"Miles","year":"2021","journal-title":"Oncologist"},{"issue":"9","key":"10.1016\/j.otc.2025.09.001_bib41","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1002\/hed.27473","article-title":"Surgical margin status and role of adjuvant therapy in human papillomavirus-positive oropharyngeal cancer","volume":"45","author":"Park","year":"2023","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.otc.2025.09.001_bib42","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ijrobp.2019.11.021","article-title":"A phase 2 trial of alternative volumes of oropharyngeal irradiation for de-intensification (AVOID): omission of the resected primary tumor bed after transoral robotic surgery for human papilloma virus-related squamous cell carcinoma of the oropharynx","volume":"106","author":"Swisher-McClure","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.otc.2025.09.001_bib43","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.ijrobp.2024.07.219","article-title":"Phase II study of radiation volume and dose de-intensification following tors and neck dissection for p16+ oropharyngeal squamous cell carcinoma \u2013 long-term results of expanded cohort","volume":"120","author":"JNea","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"19","key":"10.1016\/j.otc.2025.09.001_bib44","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa032646","article-title":"Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck","volume":"350","author":"Cooper","year":"2004","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.otc.2025.09.001_bib45","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.otc.2025.09.001_bib46","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hed.22015","article-title":"Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region","volume":"35","author":"Mehanna","year":"2013","journal-title":"Head Neck"},{"issue":"5","key":"10.1016\/j.otc.2025.09.001_bib47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/0003489417693014","article-title":"Pathologic markers in surgically treated HPV-associated oropharyngeal cancer: retrospective study, systematic review, and meta-analysis","volume":"126","author":"Tassone","year":"2017","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"11","key":"10.1016\/j.otc.2025.09.001_bib48","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/modpathol.2011.105","article-title":"Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma","volume":"24","author":"Lewis","year":"2011","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.otc.2025.09.001_bib49","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.oraloncology.2015.02.098","article-title":"High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer","volume":"51","author":"Sinha","year":"2015","journal-title":"Oral Oncol"},{"issue":"18","key":"10.1016\/j.otc.2025.09.001_bib50","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1002\/cncr.28169","article-title":"Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus status","volume":"119","author":"Maxwell","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.otc.2025.09.001_bib51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.oraloncology.2016.09.004","article-title":"Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx","volume":"62","author":"Haughey","year":"2016","journal-title":"Oral Oncol"},{"issue":"14","key":"10.1016\/j.otc.2025.09.001_bib52","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1002\/cncr.26671","article-title":"Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma","volume":"118","author":"Sinha","year":"2012","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.otc.2025.09.001_bib53","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/cncr.30598","article-title":"The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma","volume":"123","author":"An","year":"2017","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.otc.2025.09.001_bib54","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hed.21669","article-title":"Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study","volume":"33","author":"Haughey","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.otc.2025.09.001_bib55","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3389\/fonc.2019.00936","article-title":"Deintensification of adjuvant treatment after transoral surgery in patients with human papillomavirus-positive oropharyngeal cancer: the conception of the PATHOS study and its development","volume":"9","author":"Hargreaves","year":"2019","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.otc.2025.09.001_bib56","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/lary.31940","article-title":"Adjuvant radiation sparing after neoadjuvant chemotherapy and TORS in selected HPV-positive oropharyngeal cancer","volume":"135","author":"Costantino","year":"2025","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.otc.2025.09.001_bib57","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/jamaoto.2024.3303","article-title":"Neoadjuvant chemotherapy and transoral robotic surgery for human papillomavirus-related oropharyngeal cancer","volume":"151","author":"Sadeghi","year":"2025","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"14","key":"10.1016\/j.otc.2025.09.001_bib58","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1002\/cncr.31526","article-title":"Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck","volume":"124","author":"Weiss","year":"2018","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.otc.2025.09.001_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2021.103175","article-title":"Risk factors for gastrostomy tube dependence in transoral robotic surgery patients","volume":"43","author":"Philips","year":"2022","journal-title":"Am J Otolaryngol"},{"issue":"11","key":"10.1016\/j.otc.2025.09.001_bib60","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1158\/1078-0432.CCR-23-3247","article-title":"Upfront neck dissection for treatment selection and improvement in quality of life as a novel treatment paradigm for deintensification in HPV+ OPSCC","volume":"30","author":"Swiecicki","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.otc.2025.09.001_bib61","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1200\/JCO.19.02444","article-title":"Plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV-associated oropharyngeal cancer","volume":"38","author":"Chera","year":"2020","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.otc.2025.09.001_bib62","doi-asserted-by":"crossref","first-page":"15777","DOI":"10.1002\/cam4.6191","article-title":"Blood and saliva-derived ctDNA is a marker of residual disease after treatment and correlates with recurrence in human papillomavirus-associated head and neck cancer","volume":"12","author":"Ferrier","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.otc.2025.09.001_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.105776","article-title":"The future of circulating tumor DNA as a biomarker in HPV related oropharyngeal squamous cell carcinoma","volume":"126","author":"Haring","year":"2022","journal-title":"Oral Oncol"},{"issue":"20","key":"10.1016\/j.otc.2025.09.001_bib64","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1158\/1078-0432.CCR-23-1478","article-title":"Negative predictive value of circulating tumor tissue modified viral (TTMV)-HPV DNA for HPV-driven oropharyngeal cancer surveillance","volume":"29","author":"Hanna","year":"2023","journal-title":"Clin Cancer Res"},{"issue":"19","key":"10.1016\/j.otc.2025.09.001_bib65","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1158\/1078-0432.CCR-22-0562","article-title":"Detection of occult recurrence using circulating tumor tissue modified viral HPV DNA among patients treated for HPV-driven oropharyngeal carcinoma","volume":"28","author":"Berger","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.otc.2025.09.001_bib66","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ijrobp.2022.02.012","article-title":"Detectable postoperative circulating tumor human papillomavirus DNA and association with recurrence in patients with HPV-associated oropharyngeal squamous cell carcinoma","volume":"113","author":"Routman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.otc.2025.09.001_bib67","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1200\/JCO.21.01961","article-title":"Randomized trial of radiotherapy versus transoral robotic surgery for oropharyngeal squamous cell carcinoma: long-term results of the ORATOR trial","volume":"40","author":"Nichols","year":"2022","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.otc.2025.09.001_bib68","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S1470-2045(19)30410-3","article-title":"Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial","volume":"20","author":"Nichols","year":"2019","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.otc.2025.09.001_bib69","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.ejso.2015.09.007","article-title":"Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma - a systematic review of the literature","volume":"41","author":"Yeh","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.otc.2025.09.001_bib70","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/lary.26796","article-title":"Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer","volume":"128","author":"Sethia","year":"2018","journal-title":"Laryngoscope"},{"issue":"5","key":"10.1016\/j.otc.2025.09.001_bib71","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/lary.25778","article-title":"What is a clinically relevant difference in MDADI scores between groups of head and neck cancer patients?","volume":"126","author":"Hutcheson","year":"2016","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.otc.2025.09.001_bib72","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12885-020-6607-z","article-title":"Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial","volume":"20","author":"Nichols","year":"2020","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.otc.2025.09.001_bib73","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG oncology HN002)","volume":"39","author":"Yom","year":"2021","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.otc.2025.09.001_bib74","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jamaoncol.2022.0461","article-title":"The ORATOR trials have spoken-where do we go from here?","volume":"8","author":"Teckie","year":"2022","journal-title":"JAMA Oncol"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666525001288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666525001288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:29:55Z","timestamp":1772929795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666525001288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0030666525001288"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2025.09.001","relation":{},"ISSN":["0030-6665"],"issn-type":[{"value":"0030-6665","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgically Based Deintensification for Oropharyngeal Cancer","name":"articletitle","label":"Article Title"},{"value":"Otolaryngologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otc.2025.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}